NICE-recommended weight management strategies include: Dietary intervention aiming for a 600 kcal/day deficit through reduced portion sizes, limiting energy-dense foods, and increasing fruit and vegetable consumption Physical activity building up to 150300 minutes of moderate-intensity aerobic activity weekly, plus muscle-strengthening activities on at least two days weekly, in line with UK Chief Medical Officers' guidelines [10] Behavioural approaches including self-monitoring, goal-setting, and addressing emotional eating patterns Commercial weight management programmes such as those meeting NICE quality standards (QS127) Very-low-calorie diets in specific circumstances, under clinical supervision and for limited periods For patients with a BMI 30 kg/m (or 27.5 kg/m in those of South Asian, Chinese, or other Asian family origin) who have not achieved adequate weight loss through lifestyle measures alone, pharmacological interventions may be considered

People with Diagnosed B12 Deficiency or Anemia The most obvious candidates for B12 injections are individuals who have been diagnosed with a B12 deficiency or pernicious anemia
doi:10.1007/s00417-005-0108-2
Side effects are generally mild and temporary (nausea, flushing, injection site tenderness)
These dual biochemical effects make it a focal point for research on metabolic reprogramming and longevity
Cardiovascular Health Improvements: The reduction in visceral adipose tissue and improvements in lipid profiles observed with 5-amino-1MQ treatment suggest potential cardiovascular benefits